Table 2:

Estimated prevalence of extra-spinal findings by body region

Body RegionsStudiesTotalEventsProportion (95% CI)I2 (%)a
Gastrointestinal
 Overall128,10-18,20,21165929292.04 (0.29–5.22)99.2
 Men210,1529932546.90 (6.02–7.84)
 Women210,1540194608.15 (7.33–9.02)
 Men and women (≥40 years)211,2133082.31 (0.82–4.38)
Genitourinary
 Overall148,10-221768926318.74 (4.73–13.81)99.1
 Men210,15299381427.14 (25.56–28.75)
 Women210,15401972517.49 (16.33–18.68)
 Men and women (<40 years)11926900.19 (0.00–0.56)
 Men and women (≥40 years)311,19,21866828.93 (0.00–35.57)98.7
Gynecologic
 Women38,10,154289100424.03 (9.44–42.70)99.3
Vascular
 Overall138,10-18,20,22,23169412961.41 (0.73–2.30)94.0
 Men210,152993551.79 (1.34–2.30)
 Women210,154019601.42 (1.08–1.82)
 Men and women (≥40 years)211,23672537.76 (5.84–9.92)
Musculoskeletal
 Overall88,12,14-17,20,2111537540.52 (0.13–1.14)91.1
 Men115154050.32 (0.11–0.76)
 Women115247260.24 (0.09–0.53)
Metastases
 Overall78,14-17,20,218513200.28 (0.01–0.77)86.9
 Men115154000.03 (0.00–0.53)
 Women115247210.04 (0.00–0.23)
Miscellaneous
 Overall712,14-17,20,211113760.05 (0.00–0.13)21.6
 Men115154000.03 (0.00–0.53)
 Women115247200.02 (0.00–0.52)
  • Note:— Subgroups not stated if no studies reported data for such.

  • a I2 not estimable for some individual subgroups and marked as en dash.